FARGNOLI, MARIA CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 8.226
EU - Europa 4.854
AS - Asia 1.946
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 16
OC - Oceania 11
AF - Africa 2
Totale 15.074
Nazione #
US - Stati Uniti d'America 8.211
IE - Irlanda 1.831
CN - Cina 1.001
TR - Turchia 827
SE - Svezia 776
DE - Germania 508
UA - Ucraina 477
GB - Regno Unito 431
IT - Italia 350
FI - Finlandia 223
FR - Francia 130
IN - India 41
BE - Belgio 40
VN - Vietnam 37
ES - Italia 26
EU - Europa 18
RU - Federazione Russa 15
AU - Australia 10
CA - Canada 8
KR - Corea 8
NL - Olanda 7
IL - Israele 6
TW - Taiwan 6
BR - Brasile 5
HU - Ungheria 5
RS - Serbia 5
ID - Indonesia 4
JP - Giappone 4
LU - Lussemburgo 4
MX - Messico 4
PE - Perù 4
SG - Singapore 4
AR - Argentina 3
MK - Macedonia 3
PL - Polonia 3
RO - Romania 3
AL - Albania 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
MD - Moldavia 2
ME - Montenegro 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
HK - Hong Kong 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 15.074
Città #
Chandler 1.944
Jacksonville 1.918
Dublin 1.829
Izmir 422
Nanjing 335
Lawrence 306
Princeton 306
San Mateo 304
Boardman 303
Wilmington 297
New York 252
Ann Arbor 156
Ashburn 152
Milan 118
Woodbridge 113
Nanchang 108
Des Moines 86
Mountain View 80
Shenyang 73
Seattle 67
Beijing 64
Tianjin 57
Hebei 55
Verona 54
L'aquila 50
Falls Church 48
Kunming 42
Jiaxing 41
Brussels 40
Jinan 39
Dearborn 37
Dong Ket 35
Norwalk 34
Ningbo 29
Changsha 25
Helsinki 24
Zhengzhou 20
Bremen 18
Fremont 17
Pune 17
Changchun 16
Hangzhou 15
Taizhou 15
Guangzhou 13
Rome 13
Tappahannock 13
Houston 12
Philadelphia 11
Redwood City 11
Pescara 10
Auburn Hills 9
Lanzhou 9
Shanghai 9
Los Angeles 8
Redmond 8
Chapel Hill 7
Edinburgh 7
Lappeenranta 6
Lissone 6
London 6
Madrid 6
Budapest 5
Hefei 5
Hyderabad 5
Nancy 5
Phoenix 5
San Michele All'adige 5
Taipei 5
Bologna 4
Fairfield 4
Jakarta 4
Luxembourg 4
San Francisco 4
Scuola 4
Stockholm 4
Amsterdam 3
Belgrade 3
Cedar Knolls 3
Dallas 3
Frankfurt am Main 3
Grafing 3
Haikou 3
Lima 3
Menlo Park 3
Mumbai 3
Paris 3
Tokyo 3
Washington 3
Belpasso 2
Bolzano Vicentino 2
Centrale 2
Cepagatti 2
Chisinau 2
Ferentino 2
Fuzhou 2
Hanoi 2
Legnano 2
L’Aquila 2
Napoli 2
Newcastle Upon Tyne 2
Totale 10.251
Nome #
Cutaneous metastatic breast carcinoma: A study of 164 patients 181
Rapid response of scalp psoriasis to ustekinumab 95
Cutaneous manifestations in Italian kidney transplant recipients 80
Mucosal involvement in a patient with lymphomatoid papulosis 79
Long-term efficacy and safety of daylight photodynamic therapy with methyl aminolevulinate for actinic keratosis of the face and scalp 79
Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy 78
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 78
Staging and follow-up of cutaneous Melanoma patients 78
Dermoscopic features of actinic keratosis 76
Efficacy, tolerability and cosmetic acceptabilily of Toléderm® in patients with inflammatory cutaneous diseases of the face 75
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant 75
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 75
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative 75
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis 74
Diminished TCR signaling in cutaneous T-cell Iymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk 74
T-cell receptor (TCR) signal transduction: Biochemical mechanisms and possible clinical implications 74
Reduced expression of CDKN2a/p16INK4a in mycosis fungoides 74
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population 73
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair 73
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 73
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 72
Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family 72
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis 71
Pigmented reticular structures in basal cell carcinoma and collision tumours 71
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study 71
A variant in FTO shows association with melanoma risk not due to BMI 71
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity 71
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system 70
Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents 70
Molecular genetic aspects of cutaneous melanoma 69
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families 69
Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis 69
Strategy for in vitro and ex-vivo testing of neutrophins signaling pathways based on immunoproteomic array profiling 69
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location 69
Use of recombinant interferon alpha-2a in the treatment of squamous cell carcinoma 68
Acneiform follicular mucinosis of the head and neck region 68
CDKN2A/p16 expression in mycosis fungoides 68
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy 68
Knowledge of melanoma and attitude towards moles in Italian melanoma 68
Treatments of advanced basal cell carcinoma: a review of the literature 67
DIMINISHED ACTIVITY OF MEMBRANE-BOUND P50(CSK) IN CUTANEOUS T-CELL LYMPHOMA 67
Pilotropic mycosis fungoides presenting as an acneiform eruption 67
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis 67
CDKN2A alterations in patients with multiple primary melanomas 67
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy 67
Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis 66
Mycosis fungoides. Clinical and molecular biology observations 66
Current psoriasis treatments in an Italian population and their association with socio-demographical and clinical features 66
Dermoscopic features and follow-up changes of acral melanocytic naevi in childhood and dolescence. 66
Parapsoriasi 66
Unusually large cutaneous metastases of renal cell carcinoma 66
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy 66
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma 66
EDNRB gene variants and melanoma risk in two southern European populations. 66
MC1R Variants Increase Risk of Melanomas harboring BRAF Mutations 66
Cutaneous metastases of gastrointestinal malignancies 65
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype 65
Granulomatous mycosis fungoides responsive to gemcitabine 65
Pentachrome vitiligo 65
CDKN2A methylation as a predisposing factor for familial melanoma 65
Dermoscopic features of facial pigmented actinic keratosis 65
The CDKN2A A148 T variant is not associated with melanoma risk in the French and Italian populations 65
Imiquimod treatment of superficial and nodular basal cell carcinoma: a 12-week open label trial 65
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project 64
On the interplay of telomeres, nevi and the risk of melanoma 64
Gli Interferoni 64
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 64
Photodynamic therapy for basal cell carcinoma 64
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 63
Figurate eruption in a 69-year-old woman 63
Germline and somatic CDKN2A mutations in multiple primary melanoma patients. 63
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 62
CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds 62
Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna 62
Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R 62
Topical tazarotene 0.05% versus glycolic acid 70% treatment in a patient with X-linked ichthyosis 61
Figurate eruption: Erythema annulare centrifugum, deep type 61
Dermoscopic changes of Spitz/Reed nevus in childhood 61
Efficacy of tetracycline treatment to prevent the acneiform eruption secondary to cetuximab therapy 61
Teledermoscopic evaluation of 50 cases of pigmented skin lesions stored with 3 different resolutions 61
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 61
Eruptive xanthomas as revealing sign of type V hyperlipoproteinemia in a patient with a psychotic syndrome 60
Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma 60
The spectrum of dermatoscopic patterns in blue nevi 60
Photodynamic therapy for the treatment of micro invasive squamous cell carcinoma of the lower lip: a case report 60
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients 60
No evidence for linkage with melanoma in Italian melanoma-prone families 59
Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial 59
Hypo-epiluminescence microscopy of pigmented skin lesions. A new approach to improve recognition of dermoscopic structures 59
CONSTITUTIONAL AND ENVIROMENTAL RISK FACTORS FOR CUTANEOUS MELANOMA IN ITALIAN POPULATION. A CASE-CONTROL STUDY 59
The biology of melanoma 59
Efficacia e tollerabilità della terapia fotodinamica con 5-metil-aminolevulinato nel trattamento del carcinoma basocellulare 59
High-penetrance melanocortin 1 receptor gene variants contribute to sporadic cutaneous melanoma risk in the Italian population 59
Genetic Susceptibility In Familial And Multiple Melanoma Patients In Central Italy 59
Psoriasi 59
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 59
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 59
Peripheral nervous system involvement in a patient with large T-cell lymphoma arising from a pre-existing mycosis fungoides 58
Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk 58
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 58
Totale 6.791
Categoria #
all - tutte 58.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019617 0 0 0 0 0 0 0 0 0 6 40 571
2019/20201.913 407 13 220 16 16 251 405 33 264 30 9 249
2020/20212.189 15 246 2 252 241 92 304 68 289 99 452 129
2021/20221.694 96 128 308 108 56 39 23 104 175 17 131 509
2022/20235.428 394 290 94 546 454 608 4 399 2.354 31 173 81
2023/20241.178 210 67 147 204 88 355 42 52 1 12 0 0
Totale 15.537